143 related articles for article (PubMed ID: 22678621)
1. A discovery-phase urine proteomics investigation in type 1 diabetes.
Soggiu A; Piras C; Bonizzi L; Hussein HA; Pisanu S; Roncada P
Acta Diabetol; 2012 Dec; 49(6):453-64. PubMed ID: 22678621
[TBL] [Abstract][Full Text] [Related]
2. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.
Riaz S; Skinner V; Srai SK
J Pharm Biomed Anal; 2011 Mar; 54(4):817-25. PubMed ID: 21130593
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
4. Pursuing type 1 diabetes mellitus and related complications through urinary proteomics.
Caseiro A; Barros A; Ferreira R; Padrão A; Aroso M; Quintaneiro C; Pereira A; Marinheiro R; Vitorino R; Amado F
Transl Res; 2014 Mar; 163(3):188-99. PubMed ID: 24096133
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
[TBL] [Abstract][Full Text] [Related]
7. Identification of urinary biomarkers for type 2 diabetes using bead-based proteomic approach.
Chu L; Fu G; Meng Q; Zhou H; Zhang M
Diabetes Res Clin Pract; 2013 Aug; 101(2):187-93. PubMed ID: 23769013
[TBL] [Abstract][Full Text] [Related]
8. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
9. Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry.
Li B; Sheng M; Xie L; Liu F; Yan G; Wang W; Lin A; Zhao F; Chen Y
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):177-86. PubMed ID: 24282230
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of salivary biomarkers of type-2 diabetes.
Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
[TBL] [Abstract][Full Text] [Related]
11. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
12. Exploring salivary proteomes in edentulous patients with type 2 diabetes.
Border MB; Schwartz S; Carlson J; Dibble CF; Kohltfarber H; Offenbacher S; Buse JB; Bencharit S
Mol Biosyst; 2012 Apr; 8(4):1304-10. PubMed ID: 22314925
[TBL] [Abstract][Full Text] [Related]
13. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
[TBL] [Abstract][Full Text] [Related]
14. Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry.
Wang H; Feng L; Hu J; Xie C; Wang F
Exp Eye Res; 2013 Mar; 108():110-9. PubMed ID: 23276812
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
[TBL] [Abstract][Full Text] [Related]
16. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
17. Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes.
Lepedda AJ; Nieddu G; Rocchiccioli S; Fresu P; De Muro P; Formato M
Electrophoresis; 2013 Dec; 34(22-23):3227-33. PubMed ID: 24115191
[TBL] [Abstract][Full Text] [Related]
18. Comparison of urinary excretion of albumin, alpha 1-microglobulin and retinol-binding protein in diabetic patients.
Galanti LM; Jamart J; Dell'omo J; Donckier J
Diabetes Metab; 1996 Oct; 22(5):324-30. PubMed ID: 8896994
[TBL] [Abstract][Full Text] [Related]
19. Protein- versus peptide fractionation in the first dimension of two-dimensional high-performance liquid chromatography-matrix-assisted laser desorption/ionization tandem mass spectrometry for qualitative proteome analysis of tissue samples.
Melchior K; Tholey A; Heisel S; Keller A; Lenhof HP; Meese E; Huber CG
J Chromatogr A; 2010 Oct; 1217(40):6159-68. PubMed ID: 20810122
[TBL] [Abstract][Full Text] [Related]
20. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics.
Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE
Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
